Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Stock Jumps After FDA Announcement on Smokeless Tobacco Products
LXRP stock jumped by 24 percent following the FDA’s announcement FDA recently granted the first-ever, modified-risk orders to eight smokeless tobacco products DehydraTECH technology enhances oral delivery of nicotine The recent climb in the stock price of Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) looks to be the harbinger of a bright future for the innovative global developer of drug-delivery platforms. After the FDA announced it had authorized the marketing of products through the modified-risk, tobacco-product (MRTP) pathway, LXRP stock jumped 24 percent, up to $0.72 from $0.58 on the OTC Markets. The rapid rise in Lexaria stock price is…